Table 1.
Study sample characteristics
| Characteristic | Whole sample | HFrEF | HFpEF | HFmrEF | No HF |
|---|---|---|---|---|---|
| N | 33,983 (100) | 1,162 (3.4) | 2,110 (6.2) | 474 (1.4) | 30,237 (89.0) |
| Women | 19,735 (58.1) | 465 (40.0) | 1,056 (50.0) | 137 (28.9) | 18,077 (59.8) |
| Age, years, mean (SD) | 58.7 (18.2) | 67.9 (14.6) | 70.8 (14.6) | 68.8 (13.1) | 57.3 (18.1) |
| Medical History | |||||
| Coronary artery disease | 5,325 (15.7) | 510 (43.9) | 886 (42.0) | 260 (54.9) | 3,669 (12.1) |
| AF | 4,676 (13.8) | 538 (46.3) | 1,043 (49.4) | 271 57.2) | 2,824 (9.3) |
| Hypertension | 10,078 (29.7) | 684 (58.9) | 1,506 (71.4) | 293 (61.8) | 7,595 (25.1) |
| Cardiomyopathy | 874 (2.6) | 336 (28.9) | 152 (7.2) | 115 (24.2) | 272 (0.9) |
| Type 2 diabetes mellitus | 5,836 (17.2) | 440 (37.9) | 754 (35.7) | 165 (34.8) | 4,477 (14.8) |
| Renal insufficiency | 1,103 (3.2) | 175 (15.1) | 425 (20.1) | 68 (14.3) | 435 (1.4) |
| COPD | 1,373 (4.0) | 139 (12.0) | 261 (12.4) | 64 (13.5) | 909 (3.0) |
| proBNP, ng/l, mean (SD) | 1,666 (4,587) | 3,087 (6,877) | 2,357 (6,000) | 3,259 (6,318) | 77 (25) |
| eGFR, ml/min/1.73 m2, mean (SD) | 91 (27) | 84 (26) | 81 (27) | 84 (23) | 97 (27) |
| Mined EF, %, mean (SD) | 49.0 (10.3) | 34.2 (6.5) | 60.8 (7.7) | 43.8 (2.9) | 63.0 (8.4) |
Numbers are presented as n (%) unless otherwise indicated
Abbreviations: EF, ejection fraction; HFrEF, heart failure with reduced ejection fraction (< 40%); HFmrEF, heart failure with mildly reduced ejection fraction (40–49%); HFpEF, heart failure with preserved ejection fraction (